Skip to main content
. 2014 Jan 14;13:15. doi: 10.1186/1475-2840-13-15

Figure 2.

Figure 2

The changes in the levels of fasting plasma glucose (a), HbA1c (b), fasting plasma insulin (c), HOMA-R (d) and HOMA-β (e) after the treatment with glimepiride. *p < 0.05, **p < 0.01 versus before treatment. HbA1c = hemoglobin A1c, HOMA = homeostasis model assessment.